Please Wait...

SCOPE Summit for Clinical Ops Executives

February 13, 2018 - 1:00am (EST) to February 15, 2018 - 1:00am (EST)

Bioclinica exhibit: Booth #521

 

SCOPE Track: Clinical Trial Forecasting, Budgeting and Contracting

Session Date and Time: Tuesday, February 13, 2018 at 3:20pm - 3:45pm

Speaker: Meghan Harrington, VP of Operations, Payments & Forecasting, Bioclinica

Clinical Payments Case Studies: Improving Efficiency, Cash Management, and Compliance

Bioclinica’s Meghan Harrington will present case studies showing how trial sponsors and CROs are automating the clinical payments process to improve accuracy and operational efficiency, while gaining greater control over cash management. Sponsors and CROs will see how to make accurate and timely decisions based on payment milestones, actuals and trends, plus how to quickly and accurately calculate accruals to track current liabilities for payments, ultimately becoming high-performing sites' ‘partner of choice’ by replacing error-prone, manual methods with fast and accurate data-driven processes.

 

SCOPE Track: RBM: where are we and what is next?

Session Date and Time: Thursday, February 15, 2018 at 11:35 am

Speaker: Kristin Mauri, Global Head of Risk-Based Monitoring, Bioclinica

The Past, Present and Future of RBM Technology

Kristin Mauri, Bioclinica’s Global Head of Risk-Based Monitoring, will discuss the impact of ICH E6 (R2), and how risk-based monitoring technologies have evolved to provide comprehensive support for required quality management improvements.

 

Stop by booth #521 to learn how Bioclinica has helped customers such as Johnson & Johnson, Fisher Clinical Services, Premier Research, FHI 360, and others bring clarity to clinical trials and develop new life-improving therapies efficiently and safely. We look forward to seeing you in sunny Orlando!

Event Website

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil… https://t.co/77NOME2Dj7
bioclinica (Yesterday)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace… https://t.co/f9vtRpsbMW
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c… https://t.co/PAdROjo7tE
bioclinica (2 days ago)
RT @isciencebox: Draft and Final FDA Guidances Detail Development of New Drugs for Neurological Disorders @RAPSorg https://t.co/cAewLypUY7
bioclinica (2 days ago)
RT @RAPSorg: Final @US_FDA Rule Requires Medical Device Trials Outside US to Conform to GCP | #Regulatory Focus https://t.co/jgwaqxfiXl #FD…
bioclinica (2 days ago)
Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '… https://t.co/NxauNywq23
bioclinica (1 week ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen